D010087Chemicals & DrugsD01.248.497.158.685D01.650.5508120.99361OxidesFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson31099981Liu S, Hall DJ, McCarthy SM, Jacobs JJ, Urban RM, Pourzal RJournal of biomedical materials research. Part B, Applied biomaterialsFourier transform infrared spectroscopic imaging of wear and corrosion products within joint capsule tissue from total hip replacements patients. J Biomed Mater Res B Appl Biomater. 2020 02; 108(2):513-526.J Biomed Mater Res B Appl Biomater2019-05-17T00:00:002019Fourier transform infrared spectroscopic imaging of wear and corrosion products within joint capsule tissue from total hip replacements patients.true1ProfessorProfessortrue1Assistant ProfessorAssistant ProfessorNadimHallabNadim Hallab41.87352120000000-87.66713820000000349072Hallab, NadimProfessorRobinPourzalRobin Pourzal41.87352120000000-87.66713820000000349087Pourzal, RobinAssistant ProfessorRobertBalkRobert A. Balk349167Balk, RobertProfessorEunsilHahmEunsil Hahm349302Hahm, EunsilAssistant ProfessorParameswaranVenugopalParameswaran Venugopal349597Venugopal, ParameswaranProfessor6Assistant Professor4Professor15203277Raza A, Buonamici S, Lisak L, Tahir S, Li D, Imran M, Chaudary NI, Pervaiz H, Gallegos JA, Alvi MI, Mumtaz M, Gezer S, Venugopal P, Reddy P, Galili N, Candoni A, Singer J, Nucifora GLeukemia researchArsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression. Leuk Res. 2004 Aug; 28(8):791-803.Leuk Res2004-08-01T00:00:002004Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression.16015525Hassaballa HA, Lateef OB, Silver MR, Balk RAJournal of critical careAcute lung injury induced by arsenic trioxide in a patient with refractory myelodysplastic syndrome. J Crit Care. 2005 Mar; 20(1):111-3.J Crit Care2005-03-01T00:00:002005Acute lung injury induced by arsenic trioxide in a patient with refractory myelodysplastic syndrome.0.3696110.06360348research area of0.3079760.06475788subject area for17607291Farhat M, Venugopal PClinical advances in hematology & oncology : H&OLong-term remission of extramedullary relapse from acute promyelocytic leukemia after treatment with arsenic trioxide, intrathecal chemotherapy, and brain irradiation. Clin Adv Hematol Oncol. 2007 Apr; 5(4):320-3; discussion 323-4.Clin Adv Hematol Oncol2007-04-01T00:00:002007Long-term remission of extramedullary relapse from acute promyelocytic leukemia after treatment with arsenic trioxide, intrathecal chemotherapy, and brain irradiation.Orthopedic SurgeryRush University, Rush Medical CollegeInternal Medicine, Division of Hematology/Oncology/Cell Therapytrue1ProfessorProfessor15547942Han SS, Kim K, Hahm ER, Park CH, Kimler BF, Lee SJ, Lee SH, Kim WS, Jung CW, Park K, Kim J, Yoon SS, Lee JH, Park SJournal of cellular biochemistryArsenic trioxide represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60. J Cell Biochem. 2005 Mar 01; 94(4):695-707.J Cell Biochem2005-03-01T00:00:002005Arsenic trioxide represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60.true1Assistant ProfessorAssistant Professortrue1ProfessorProfessorInternal Medicine, Division of NephrologyInternal Medicine, Division of Pulmonary Disease Critical Care